In light of the most significant association of ZIP13 with the survival of ovarian cancer patients (P = 7.50E-07 for OS, and P = 1.10E-11 for PFS), we thus assumed that ZIP13 was one of the most promising ZIP transporters in ovarian cancer. Here, SLC39A13 is linked to ovarian cancer.